Literature DB >> 21837795

Congenital cytomegalovirus infection in the Netherlands: birth prevalence and risk factors.

Jutte J C de Vries1, Anna M H Korver, Paul H Verkerk, Lisette Rusman, Eric C J Claas, J Gerard Loeber, Aloys C M Kroes, Ann C T M Vossen.   

Abstract

Congenital cytomegalovirus (CMV) infection is the most common congenital viral infection worldwide. The sequela encountered most frequently is hearing impairment, affecting approximately one out of five infants congenitally infected. Data on the birth prevalence and risk factors of congenital CMV infection in the Netherlands are scarce. The aim of this study was to determine the birth prevalence of congenital CMV in the Netherlands. A sample of 6,500 dried blood spots (DBS) from infants born in the Netherlands was tested anonymously for CMV DNA. The sample was stratified by the number of live births in different regions of the Netherlands of the year 2007. Additionally, on a regional level, risk factors for congenital CMV were analyzed. The birth prevalence of congenital CMV in the Netherlands was 0.54% (35/6,433, 95%CI 0.36-0.72). Congenital CMV infection was significantly higher in regions with more than 15% young children (0-5 years) compared with regions with a lower proportion of young children (OR 5.9, 95%CI 1.4-25.2). Congenital CMV infection was significantly higher in regions with more than 30% immigrants compared with regions with a lower proportion of immigrants (OR 2.2, 95%CI 1.1-4.6). This association was strongest for regions with more than 30% non-Western immigrants (OR 3.3, 95%CI 1.5-7.5). Based on the knowledge of the natural history of congenital CMV infection, approximately 1,000 children are born with congenital CMV infection in the Netherlands annually, of whom eventually approximately 180 children (0.1% of all newborns) will be affected by long term sequelae, with hearing loss being the symptom encountered most frequently.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21837795     DOI: 10.1002/jmv.22181

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  12 in total

1.  Rapid genotyping of cytomegalovirus in dried blood spots by multiplex real-time PCR assays targeting the envelope glycoprotein gB and gH genes.

Authors:  Jutte J C de Vries; Els Wessels; Anna M H Korver; Annemiek A van der Eijk; Lisette G Rusman; Aloys C M Kroes; Ann C T M Vossen
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

Review 2.  The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?

Authors:  Mark R Wills; Emma Poole; Betty Lau; Ben Krishna; John H Sinclair
Journal:  Cell Mol Immunol       Date:  2014-08-18       Impact factor: 11.530

3.  Observational study to assess pregnant women's knowledge and behaviour to prevent toxoplasmosis, listeriosis and cytomegalovirus.

Authors:  Monique T R Pereboom; Judith Manniën; Evelien R Spelten; François G Schellevis; Eileen K Hutton
Journal:  BMC Pregnancy Childbirth       Date:  2013-04-30       Impact factor: 3.007

4.  Impact of socioeconomic risk factors on the seroprevalence of cytomegalovirus infections in a cohort of pregnant Polish women between 2010 and 2011.

Authors:  W Wujcicka; Z Gaj; J Wilczyński; W Sobala; E Spiewak; D Nowakowska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-06       Impact factor: 3.267

5.  Genotype distribution, viral load and clinical characteristics of infants with postnatal or congenital cytomegalovirus infection.

Authors:  Joppe Nijman; Femke S Mandemaker; Malgorzata A Verboon-Maciolek; Susan C Aitken; Anton M van Loon; Linda S de Vries; Rob Schuurman
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

6.  Blood donor safety, prevalence and associated factors for cytomegalovirus infection among blood donors in Minna-Nigeria, 2014.

Authors:  Musa Kalamullah Bawa; Aisha Mamman; Adebola Olayinka; Saheed Gidado; Ndadilnasiya Endie Waziri; Muhammad Shakir Balogun; Kabir Ibrahim Getso; Mahmood Muazu Dalhat; Peter Nsubuga; Nuruddeen Aliyu; Hussaini Bala; Hauwa Muhammad; Suleiman Haladu; Usman Lawan Shehu; Patrick Mboya Nguku
Journal:  Pan Afr Med J       Date:  2019-01-22

7.  Genotypes of glycoprotein B gene among the Indian symptomatic neonates with congenital CMV infection.

Authors:  Agniswar Sarkar; Dipanwita Das; Sabbir Ansari; Rajendra Prasad Chatterjee; Lopamudra Mishra; Biswanath Basu; Sanat Kumar Ghosh; Mala Bhattacharyay; Nilanjan Chakraborty
Journal:  BMC Pediatr       Date:  2019-08-22       Impact factor: 2.125

8.  The association between antibodies to neurotropic pathogens and bipolar disorder : A study in the Dutch Bipolar (DB) Cohort and meta-analysis.

Authors:  Gijsje J L J Snijders; Hans C van Mierlo; Marco P Boks; Marieke J H Begemann; Arjen L Sutterland; Manja Litjens; Roel A Ophoff; René S Kahn; Lot D de Witte
Journal:  Transl Psychiatry       Date:  2019-11-20       Impact factor: 6.222

9.  Maternal cytomegalovirus immune status and hearing loss outcomes in congenital cytomegalovirus-infected offspring.

Authors:  Gail J Demmler-Harrison; Jerry A Miller
Journal:  PLoS One       Date:  2020-10-09       Impact factor: 3.240

10.  Disease burden of congenital cytomegalovirus infection at school entry age: study design, participation rate and birth prevalence.

Authors:  M J Korndewal; A C T M Vossen; J Cremer; R S VAN Binnendijk; A C M Kroes; M A B VAN DER Sande; A M Oudesluys-Murphy; H E DE Melker
Journal:  Epidemiol Infect       Date:  2015-11-11       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.